Isofol Q1 2022: AGENT’s mission enters its final stages - Redeye

Redeye comments on Isofol’s Q1 2022 report, with the company closing in on critical AGENT top-line data. We estimate Isofol will communicate top-line data between late June and late August of this year. We judge that the company’s cash position extends well beyond AGENT top-line data and a potential NDA submission in H2 2022.

Länk till analysen i sin helhet: https://www.redeye.se/research/841778/isofol-q1-2022-agents-mission-enters-its-final-stages?utm_source=finwire&utm_medium=RSS